|
Home > Archive > Kidney Failure > July 2006 > Amgen to start chronic kidney disease study
You are viewing an archived Text-only version of the thread.
To view this thread in it's original format and/or if you want to reply to
this thread please [click here]
| Author |
Amgen to start chronic kidney disease study
|
|
|
| Amgen to start chronic kidney disease study
U.S. biotechnology company Amgen Inc. said on Sunday it will start a
large-scale drug study of its Sensipar/Mimpara drugs in chronic kidney
disease patients.
The late-stage, Phase 3, study will enroll 3,800 patients around the
world, Amgen said.
Amgen said enrollment in the study is expected to begin in the second
half of 2006.
| |
|
| Uhm, Like the phase 3 trials and the ultimate approval have already
taken place. The drug is on the market and being prescribed now. By
the way, it works very well.
Dave
Alan <Spam@aol.com> wrote in news:y8Cug.21290$ci.15288@news-wrt-01.rdc-
nyc.rr.com:
> Amgen to start chronic kidney disease study
>
>
>
> U.S. biotechnology company Amgen Inc. said on Sunday it will start a
> large-scale drug study of its Sensipar/Mimpara drugs in chronic kidney
> disease patients.
>
> The late-stage, Phase 3, study will enroll 3,800 patients around the
> world, Amgen said.
>
> Amgen said enrollment in the study is expected to begin in the second
> half of 2006.
>
|
| |
|
|